BioNexus Gene Lab BGLC Stock
BioNexus Gene Lab Price Chart
BioNexus Gene Lab BGLC Financial and Trading Overview
| BioNexus Gene Lab stock price | 2.28 USD |
| Previous Close | 2.32 USD |
| Open | 2.22 USD |
| Bid | 1.61 USD x 200 |
| Ask | 2.8 USD x 200 |
| Day's Range | 2.19 - 2.4 USD |
| 52 Week Range | 1.92 - 15.6 USD |
| Volume | 9.89K USD |
| Avg. Volume | 12.94K USD |
| Market Cap | 5.41M USD |
| Beta (5Y Monthly) | 2.187 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.49 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BGLC Valuation Measures
| Enterprise Value | 1.8M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.019603 |
| Price/Book (mrq) | 0.6690561 |
| Enterprise Value/Revenue | 0.338 |
| Enterprise Value/EBITDA | -0.607 |
Trading Information
BioNexus Gene Lab Stock Price History
| Beta (5Y Monthly) | 2.187 |
| 52-Week Change | -35.072% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 15.6 USD |
| 52 Week Low | 1.92 USD |
| 50-Day Moving Average | 2.2 USD |
| 200-Day Moving Average | 3.69 USD |
BGLC Share Statistics
| Avg. Volume (3 month) | 12.94K USD |
| Avg. Daily Volume (10-Days) | 55.66K USD |
| Shares Outstanding | 2.42M |
| Float | 1.75M |
| Short Ratio | 2.34 |
| % Held by Insiders | 35.58% |
| % Held by Institutions | 0.010% |
| Shares Short | 10.57K |
| Short % of Float | 0.52% |
| Short % of Shares Outstanding | 0.44% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -54.69% |
| Operating Margin (ttm) | -2466.010% |
| Gross Margin | 13.95% |
| EBITDA Margin | -55.76% |
Management Effectiveness
| Return on Assets (ttm) | -20.75% |
| Return on Equity (ttm) | -36.62% |
Income Statement
| Revenue (ttm) | 5.31M USD |
| Revenue Per Share (ttm) | 2.64 USD |
| Quarterly Revenue Growth (yoy) | -98.90% |
| Gross Profit (ttm) | 740.93K USD |
| EBITDA | -2961790 USD |
| Net Income Avi to Common (ttm) | -2904855 USD |
| Diluted EPS (ttm) | -1.48 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.96M USD |
| Total Cash Per Share (mrq) | 1.64 USD |
| Total Debt (mrq) | 346.62K USD |
| Total Debt/Equity (mrq) | 4.28 USD |
| Current Ratio (mrq) | 6.524 |
| Book Value Per Share (mrq) | 3.348 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1161981 USD |
| Levered Free Cash Flow (ttm) | -170052 USD |
Profile of BioNexus Gene Lab
| Country | United States |
| State | N/A |
| City | Kuala Lumpur |
| Address | Menara UOA Bangsar |
| ZIP | 59000 |
| Phone | 60 1 307 241 6898 |
| Website | https://www.bionexusgenelab.com |
| Industry | Specialty Chemicals |
| Sector(s) | Basic Materials |
| Full Time Employees | 19 |
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Q&A For BioNexus Gene Lab Stock
What is a current BGLC stock price?
BioNexus Gene Lab BGLC stock price today per share is 2.28 USD.
How to purchase BioNexus Gene Lab stock?
You can buy BGLC shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioNexus Gene Lab?
The stock symbol or ticker of BioNexus Gene Lab is BGLC.
Which industry does the BioNexus Gene Lab company belong to?
The BioNexus Gene Lab industry is Specialty Chemicals.
How many shares does BioNexus Gene Lab have in circulation?
The max supply of BioNexus Gene Lab shares is 2.42M.
What is BioNexus Gene Lab Price to Earnings Ratio (PE Ratio)?
BioNexus Gene Lab PE Ratio is now.
What was BioNexus Gene Lab earnings per share over the trailing 12 months (TTM)?
BioNexus Gene Lab EPS is -1.49 USD over the trailing 12 months.
Which sector does the BioNexus Gene Lab company belong to?
The BioNexus Gene Lab sector is Basic Materials.
BioNexus Gene Lab BGLC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
- {{ link.label }} {{link}}